德宏股份(603701.SH)擬購買伯坦科技100%股權 明起停牌
格隆匯5月18日丨德宏股份(603701.SH)公佈,公司正在籌劃以發行股份或可轉換債券及支付部分現金的方式收購杭州伯坦科技工程有限公司(以下簡稱“伯坦科技”)100%股權並募集配套資金。目前該事項仍處於洽談階段,相關方正在積極協商溝通中。
公司同時擬在進行控制權轉讓,轉讓成功後的新控股股東(天堂硅谷資產管理集團有限公司或其指定方)與伯坦科技不存在關聯關係。控制權轉讓與本次重大資產重組兩項交易不互為前提,本次重大資產重組不會導致公司實際控制人發生變更。
公司股票自2020年5月19日(星期二)開市起停牌,預計停牌時間不超過10個交易日(含2020年5月18日緊急臨時停牌一天)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.